108 related articles for article (PubMed ID: 36228564)
1. Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
Iida T; Hosojima M; Kabasawa H; Yamamoto-Kabasawa K; Goto S; Tanaka T; Kitamura N; Nakada M; Itoh S; Ogasawara S; Kaseda R; Suzuki Y; Narita I; Saito A
J Diabetes Complications; 2022 Nov; 36(11):108312. PubMed ID: 36228564
[TBL] [Abstract][Full Text] [Related]
2. Association of urinary C-megalin with albuminuria and renal function in diabetes: a cross-sectional study (Diabetes Distress and Care Registry at Tenri [DDCRT 21]).
Kurita N; Kinoshita M; Fujimura M; Kurosawa K; Sakuramachi Y; Takano K; Okamura S; Kitatani M; Tsujii S; Norton EC; Hayashino Y;
J Nephrol; 2022 Jan; 35(1):201-210. PubMed ID: 33646560
[TBL] [Abstract][Full Text] [Related]
3. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
4. Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.
Jiang X; Zhang Q; Wang HB; Cui XF; Liu R
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28236320
[TBL] [Abstract][Full Text] [Related]
5. Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.
Ogasawara S; Hosojima M; Kaseda R; Kabasawa H; Yamamoto-Kabasawa K; Kurosawa H; Sato H; Iino N; Takeda T; Suzuki Y; Narita I; Yamagata K; Tomino Y; Gejyo F; Hirayama Y; Sekine S; Saito A
Diabetes Care; 2012 May; 35(5):1112-8. PubMed ID: 22410816
[TBL] [Abstract][Full Text] [Related]
6. Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24).
Niihata K; Nishiwaki H; Kinoshita M; Kurosawa K; Sakuramachi Y; Matsunaga S; Okamura S; Tsujii S; Hayashino Y; Kurita N;
Acta Diabetol; 2023 Dec; 60(12):1643-1650. PubMed ID: 37439857
[TBL] [Abstract][Full Text] [Related]
7. A Pre-Post Study of Vitamin D Supplement Effects on Urinary Megalin: The Emerging Predictive Role of Megalin in Diabetic Nephropathy Progression.
Kasabri V; Akour A; Bulatova N; Suyagh M; Yousef AM; Al Hawari H; Al Shelleh S; Bzour J; Fahmawi H
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1552-1557. PubMed ID: 32448110
[TBL] [Abstract][Full Text] [Related]
8. Urinary megalin in association with progression factors of diabetic nephropathy.
Akour A; Kasabri V; Bulatova N; Al-Motassem Y; Fahmawi H; Momani M; Zayed A; Alquoqa R; AlHawari H
Bratisl Lek Listy; 2019; 120(7):532-535. PubMed ID: 31602990
[TBL] [Abstract][Full Text] [Related]
9. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
10. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m
Nitta K; Nagai T; Mizunuma Y; Kitada M; Nakagawa A; Sakurai M; Toyoda M; Haneda M; Kanasaki K; Koya D
Clin Exp Nephrol; 2019 Aug; 23(8):1004-1012. PubMed ID: 30949886
[TBL] [Abstract][Full Text] [Related]
11. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
12. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
13. Urinary C-megalin for screening of renal scarring in children after febrile urinary tract infection.
Yamanouchi S; Kimata T; Kino J; Kitao T; Suruda C; Tsuji S; Kurosawa H; Hirayama Y; Saito A; Kaneko K
Pediatr Res; 2018 Mar; 83(3):662-668. PubMed ID: 29211055
[TBL] [Abstract][Full Text] [Related]
14. Association of metabolic syndrome traits with urinary biomarkers in Japanese adults.
Kabasawa K; Hosojima M; Ito Y; Matsushima K; Tanaka J; Hara M; Nakamura K; Narita I; Saito A
Diabetol Metab Syndr; 2022 Jan; 14(1):9. PubMed ID: 35033174
[TBL] [Abstract][Full Text] [Related]
15. Exocytosis-Mediated Urinary Full-Length Megalin Excretion Is Linked With the Pathogenesis of Diabetic Nephropathy.
De S; Kuwahara S; Hosojima M; Ishikawa T; Kaseda R; Sarkar P; Yoshioka Y; Kabasawa H; Iida T; Goto S; Toba K; Higuchi Y; Suzuki Y; Hara M; Kurosawa H; Narita I; Hirayama Y; Ochiya T; Saito A
Diabetes; 2017 May; 66(5):1391-1404. PubMed ID: 28289043
[TBL] [Abstract][Full Text] [Related]
16. Beta-Hydroxybutyric Acid Inhibits Renal Tubular Reabsorption via the AKT/DAB2/Megalin Signalling Pathway.
Zuo M; Meng C; Song Q; Gao Z; Cui X; Wang J; Li Y; Li X; Shan C; Yang J; Chang B
J Diabetes Res; 2022; 2022():3411123. PubMed ID: 36330072
[TBL] [Abstract][Full Text] [Related]
17. Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.
Pan L; Wo M; Xu C; Wu Y; Ye Y; Han F; Fei X; Zhu F
PLoS One; 2022; 17(7):e0271181. PubMed ID: 35802685
[TBL] [Abstract][Full Text] [Related]
18. Urinary N-acetyl-β-d-glucosaminidase-creatine ratio is a valuable predictor for advanced diabetic kidney disease.
Huang Q; Fei X; Zhan H; Gong J; Zhou J; Zhang Y; Ye X; Song Y; Ma J; Wu X
J Clin Lab Anal; 2023 Jan; 37(1):e24769. PubMed ID: 36572996
[TBL] [Abstract][Full Text] [Related]
19. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy.
Fukuda A; Minakawa A; Kikuchi M; Sato Y; Nagatomo M; Nakamura S; Mizoguchi T; Fukunaga N; Shibata H; Naik AS; Wiggins RC; Fujimoto S
Sci Rep; 2020 Oct; 10(1):18209. PubMed ID: 33097787
[TBL] [Abstract][Full Text] [Related]
20. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
